Mangoceuticals, Inc. (MGRX) Total Return Calculator with Dividends Reinvested

Mangoceuticals, Inc.

Popular:

The total return for Mangoceuticals, Inc. (MGRX) stock is -83.31% over the past 12 months. So far it's down 61.47% this year. The 5-year total return is -99.45%, meaning $10,000 invested in MGRX stock 5 years ago would be worth $55 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in MGRX 1 year ago, it would be worth $1,767 today — you'd have lost $8,233.

With Dividends Reinvested$1,767-82.33%

Price Only (No DRIP)$1,767-82.33%

Period2025-06-23 → 2026-06-18

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in MGRX

1Y$1,669-$8,331 (-83.3%)-83.3% CAGR

3Y$131-$9,869 (-98.7%)-76.4% CAGR

5Y$55-$9,945 (-99.5%)-64.7% CAGR

10Y$55-$9,945 (-99.5%)-40.6% CAGR

15Y$55-$9,945 (-99.5%)-29.3% CAGR

20Y$55-$9,945 (-99.5%)-22.9% CAGR

30Y$55-$9,945 (-99.5%)-15.9% CAGR

Mangoceuticals, Inc. did not pay dividends during this period. Total return = price return.

Loading MGRX total return...

As of 2026-06-22

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-61.47%	—	-61.47%	—	$3,853
1Y	-83.31%	-83.31%	-83.31%	—	$1,669
3Y	-98.69%	-76.41%	-98.69%	—	$131
5Y	-99.45%	-64.70%	-99.45%	—	$55
10Y	-99.45%	-40.59%	-99.45%	—	$55
15Y	-99.45%	-29.33%	-99.45%	—	$55
20Y	-99.45%	-22.92%	-99.45%	—	$55
30Y	-99.45%	-15.93%	-99.45%	—	$55

Risk & Highlights

Best Year-44.50%2024

Worst Year-93.08%2023

Max Drawdown-89.75%2025-10-21 → 2026-03-20

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-37.28%	-37.28%	—	+0.41%	-37.7pp
2025	-70.28%	-70.28%	—	+16.64%	-86.9pp
2024	-44.50%	-44.50%	—	+24.00%	-68.5pp
2023	-93.08%	-93.08%	—	+24.81%	-117.9pp

MGRX underperformed the S&P 500 by 108.30pp over the past year (-83.31% vs +24.99%).

Loading summary...

MGRX Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
MGRXMangoceuticals, Inc.	$3M	-18.8%	-61.5%	-83.3%	—	-98.7%	-99.5%	-99.5%
HIMSHims & Hers Health, Inc.	$7.8B	+59.1%	+6.2%	-41.9%	—	+324.8%	+219.5%	+261.9%
MNMDMind Medicine (MindMed) Inc.	$2.0B	—	+51.7%	+191.8%	—	+473.1%	-63.1%	+512.1%
AMWLAmerican Well Corporation	$141M	+8.6%	+73.8%	+23.8%	—	-81.2%	-96.9%	-98.2%
TDOCTeladoc Health, Inc.	$1.5B	+27.1%	+14.5%	+15.1%	—	-67.6%	-94.8%	-37.7%
OPRXOptimizeRx Corporation	$93M	-2.2%	-59.9%	-62.0%	—	-66.2%	-90.4%	+53.7%
WELLWelltower Inc.	$144.8B	-2.8%	+11.3%	+36.8%	+1.9pp	+171.1%	+179.7%	+221.6%
DOCSDoximity, Inc.	$3.8B	+4.5%	-52.7%	-64.1%	—	-35.5%	-61.4%	-61.4%
PFEPfizer Inc.	$143.5B	-0.4%	+3.6%	+12.8%	+7.2pp	-23.0%	-13.7%	+23.7%
NUVBNuvation Bio Inc.	$1.9B	+32.1%	-35.2%	+210.6%	—	+212.4%	-42.5%	-44.4%
ATAIAtai Beckley N.V	$1.5B	-2.2%	+4.9%	+74.2%	—	+124.3%	-79.6%	-47.5%

Compare:MGRX vs HIMS MGRX vs MNMD MGRX vs AMWL MGRX vs HIMS vs MNMD

About MGRX Dividend Returns

Mangoceuticals, Inc. (MGRX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of MGRX over the past year?

Mangoceuticals, Inc. (MGRX) delivered a return of -83.31% over the past year. Since MGRX does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in MGRX be worth today?

A $10,000 investment in Mangoceuticals, Inc. one year ago would be worth $1,669 today, representing a loss of $8,331.

Q3Does MGRX pay dividends?

Mangoceuticals, Inc. (MGRX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For MGRX, the total return equals the price-only return.

Q4Did MGRX beat the S&P 500?

No, Mangoceuticals, Inc. (MGRX) underperformed the S&P 500 by 108.30 percentage points over the past year. MGRX delivered a total return of -83.31%, compared to the S&P 500's 24.99%. This means a passive S&P 500 index fund outperformed MGRX by 108.30pp during this period.

Q5What is MGRX's worst drawdown?

Mangoceuticals, Inc. (MGRX) experienced a maximum drawdown of -89.75% over the past year, declining from its peak on 2025-10-21 to its trough on 2026-03-20. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is MGRX's long-term total return over 10, 20, or 30 years?

Here are Mangoceuticals, Inc. (MGRX)'s long-term returns with dividends reinvested. Over 10 years, the total return is -99.5% (-40.6% CAGR) — $10,000 would have grown to $55. Over 20 years: -99.5% total return (-22.9% CAGR) — $10,000 → $55. Over 30 years: -99.5% total return (-15.9% CAGR) — $10,000 → $55. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was MGRX's best and worst year?

Mangoceuticals, Inc.'s best calendar year was 2024 with a total return of -44.5%. Its worst year was 2023 with a total return of -93.1%. This range shows the volatility investors should expect — the difference between the best and worst year is 48.6 percentage points.

How much would $100/month in MGRX be worth today?

Dollar cost averaging calculator · DCA vs lump sum · see how regular investing compounds

Run the Numbers →